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Exposure of human renal proximal tubular cells to glucose leads
to accumulation of type IV collagen and fibronectin by decreased
degradation
ALED 0. PHILLIPS, ROBERT STEADMAN, KIMBERLEY MORRISEY, JOHN MARTIN, LISA EYNSTONE,
and JOHN D. WILLIAMS
Institute of Nephrology, University of Wales College of Medicine, Cardiff Royal Infirmaiy, Newport Road, Cardiff Wales, United
Kingdom
Exposure of human renal proximal tubular cells to glucose leads to
accumutation of type IV collagen and fibronectin by decreased degrada-
tion. Thickening and reduplication of the tubular basement membrane has
been reported as an early event in diabetic nephropathy. In the current
study we examined the effects of elevated D-glucose concentrations on
human proximal tubular (HPTC) type IV collagen and fibronectin turn-
over. Incubation of confluent growth arrested HPTC with 25 mM D-
glucose led to accumulation of both type IV collagen and fibronectin. This
effect was maximal at 48 hours and represented a sevenfold increase for
fibronectin (N = 4, p = 0.04), and a threefold increase for type IV
collagen (N = 3,P = 0.03) over cells exposed to 5 mvi D-glucose controls.
This increase was not dependent on new gene transcription for either
protein. Tissue inhibitor of metalloproteinases (TIMP I + TIMP 2) were
induced following addition of 25 mu D-glucose, but not when cells were
exposed to 5 mvi D-glucose. Twenty-four hours after the addition of 25
mM D-glucosc there was an eightfold increase in TIMP 1 (P 0.009, N =
4), and a tenfold increase in TIMP 2 levels (P = 0.003, N = 4), over the
control values for both inhibitors. The increase in both TIMP 1 and TIMP
2 in response to 25 mat D-glucose was abrogated in a dose dependent
manner by the aldose reductase inhibitor sorhinil. Gelatin-substrate gel
zymography showed increased activity of gelatinase A, but not of gelati-
nase B in response to the addition of 25 mu D-glucose to HPTC. The
induction of gelatinase A was accompanied by increased gelatinase A
mRNA expression, which was inhibited both by protein kinase C (PKC)
depletion using PMA pre-treatment, and by the addition of a PKC
inhibitor. These data demonstrate that the glucose-induced accumulation
of type IV collagen and fibronectin is unrelated to increased gene
transcription, but may involve alterations in the degradative pathway of
these basement membrane constituents. Furthermore, the data demon-
strate that glucose may simultaneously activate two intracellular pathways
(the polyol pathway and a PKC dependent activation pathway), which are
involved in mediating separate, complementary effects on cell function.
Nephropathy is a major cause of morbidity and mortality in
diabetes and is the single most common cause of end-stage renal
failure requiring renal replacement therapy [1, 2]. In the past it
has been considered to he primarily a glomerutar disease. There
is now strong evidence, however, that a progressive decline in
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renal function is also closely correlated with the development of
tubulointerstitial lesions [3, 41. As a result several studies have
focused on the mechanisms of induction of these interstitial
changes.
There are clear epidemiological data to indicate that both the
initiation and the progression of nephropathy are related to poor
glycemic control, and that strict metabolic control can delay both
the onset and the rate of progression [5, 61. One of the earliest
pathological changes in the renal tubulointerstitium in diabetes, is
an increase in tubular basement membrane (TBM) mass that
accompanies the development of renal hypertrophy. These
changes in the TBM occur before any histological changes within
the glomerulus [7].
Previous studies have demonstrated alterations in synthesis of
extracellular matrix (ECM) constituents by various cell types in
response to exposure to elevated D-glucose concentrations [8—
ii]. Alterations in the deposition of basement membrane constit-
uents may result from either an increase in their production or a
decrease in their degradation. A detailed analysis of ECM com-
ponents produced by proximal tubular cells has not been carried
out. Recent evidence, however, has shown that proximal tubular
cells can produce a number of pro-inflammatory molecules en-
abling them to initiate and influence pathological changes in the
renal interstitium [12—14]. In the current study we have examined
the effects of glucose on type IV collagen and fibronectin synthesis
in cultured human proximal tubular epithelial cells (HPTC). In
addition, we have examined associated changes in the synthesis
and activity of matrix metalloproteinases and their inhibitors,
under the same conditions. By studying the effect of glucose on
the synthetic and the degradativc pathways of matrix turnover, we
have assessed the net effect of glucnse on matrix accumulation.
In addition to describing the alterations in the basement
membrane constituents seen in response to the exposure of
proximal tubular cells to elevated D-glucose concentrations, we
have also examined mechanisms by which these changes may
occur. Previous studies have suggested that effects of glucose on
extracellular matrix may be mediated by the pro-fibrotic cytokine
transforming growth factor J31 (TGF-f31) [15—17]. Our previous
published observations, however, demonstrated that exposure of
HPTC to elevated D-glucose concentrations induced TGF-f1
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Table 1. Amplification primer
Gene Primers Product size Reference
Type IV (al) 5'-CAATGCCCI17CCTGTTCTGC-3' 435bp [311
Coflagen 5'-GTGGACGGCGTAGGCTFCTT-3'
Fibronectin 5'-AGCCGCCACGTGCCAGGA117AC-3'
5'-CYTATGGGGGTGGCCGTFGTGG-3
439bp [32]
Gelatinase A 5'-TITFCTCGAATCCATGATGG-3'
5'-CTGGTGCAGCTCTCATA1TF-3'
630bp [33]
TIMP-1 5'-ATCCTGTTGTTGCTGTGGCTG-3' 520bp [34]
5 '-GACTGGAAGCCCTTTrCAGA-3'
TIMP-2 5'-GTITTGCAATGCAGATGTAG-3'
5 '-ATGTCGAGAAACTCCTGCTF-3'
540bp [35]
a-Actin 5'-CCVfCCTGGGCATGGAGTCCT-3'
5 '-GGAGCAATGATCTFGATCTr-3
204bp [361
mRNA synthesis without any associated change in TGF-pl pro-
tein synthesis [18, 19]. In these studies the application of a second
stimulus, such as either PDGF or IL-1, was required to trigger
TGF-131 protein secretion [13, 18]. Further experiments were
therefore performed to assess a possible role for TGF-f31 in the
glucose mediated alterations in type IV collagen and fibronectin
turnover by HPTC.
Numerous biochemical mechanisms have been postulated
which could lead to functional changes or tissue damage in
diabetes mellitus as a result of hyperglycemia. There is a large
body of experimental evidence that activation of the poiyol
pathway and activation of the protein kinase C system may both
be mechanisms forming a link between hyperglycemia and dia-
betic nephropathy [20—22]. In the current study the relative
contributions of these potential mechanisms to the observed
changes in type IV collagen and fibronectin accumulation were
assessed.
The results of the present study indicate that 25 mM D-glucose
increased type IV collagen and fibronectin concentrations, and
that these alterations were not dependent on gene transcription.
Furthermore the data presented suggest that alterations in the
degradative pathway contributed to the accumulation of these
matrix components.
METHODS
Materials
D- and L-isoforms of glucose, mannitol, phorbol 12-myristate
13 acetate (PMA), and p-Aminophenylmercuric acetate (PAMA)
were purchased from Sigma Chemicals (Poole, UK); Tris, CaCI2,
Brij and actylamide from Imperial Laboratories (Europe) Ltd,
and Coomasic Blue from BioRad laboratories Ltd. Blocking
experiments were performed in duplicate using pan-specific anti-
TGF- antibody (Genzyme Diagnostics, Cambridge, MA, USA;
Ref 80-1835-03). The aldose reductase inhibitor, sorbinil, was a
gift from Pfizer Central Research (Pfizer Inc, Groton, CT, USA),
and the PKC inhibitor, RO 31-8220/002, was a gift from Roche
Pharmaceuticals.
Cell culture
HPTC were isolated and characterised as previously described
[18]. Briefly, small fragments of human renal cortical tissue
obtained from nephreetomy specimens were passed through a
series of mesh sieves, and proximal tubular cells recovered from
material retained on a 53-jsm pore size sieve. The collected
material was digested with collagenase (750 U/ml) for 10 mm, and
tubular cells isolated by centrifugation. Growth medium for
primary and subsequent cultures comprised a 1:1 mixture of
DMEM/Ham's F12 with 10% FCS supplemented with insulin (5
g/ml), transferrin (5 jsg/ml), selenium (5 ng/ml), and hydrocor-
tisone (40 ng/ml). Culture media and supplements were obtained
from Life Technologies Ltd, (Paisley, Scotland, UK). Cells were
grown at 37°C in 5% CO2 and 95% air. HPTC were characterized
to be of proximal tubular origin by enzyme histochemistry and
immunofluorescence. Cells stained positively for alkaline phos-
phatase, acid phosphatase, non-specific esterase, and glucose-6-
phosphatase, a pattern which is specific for proximal tubular
epithelial cells [21—23]. In addition, cells were positive for cyto-
keratin and negative for Tamm-Horsfall glycoprotein. Electron
microscopy demonstrated the presence of a rudimentary brush
border. We have previously demonstrated the viability of HPTC
in serum-free media for times up to 10 days [18]. All experiments
were performed under serum free conditions following a "growth
arrest" period of 72 hours in serum free medium. In all experi-
ments cells were used only up to the third passage. We have
previously demonstrated that there were no phenotypic changes
up to this passage number [18].
Determination of fibronectin, type 1Y collagen and TIMP
protein concentrations
Fibronectin concentration in culture supernatant was deter-
mined using an antibody competition ELISA (24].
Type IV collagen in supernatant samples was measured by
specific antibody competition ELISA [251. The assay is sensitive to
1 ng/ml with a range up to 200 ng/ml. Inter-assay precision ranged
from 2 to 14%, (CV) and iritra-assay precision ranged from 2 to
10% (CV). There was no detectable cross reactivity with type I
collagen. Rabbit anti-human type IV collagen antibody was
obtained from Manosan (Bradsure Biologicals, Market Harbor-
ough, UK). It has been previously demonstrated that this antibody
reacted with the ul and s2 procollagen chains as well as the s
chains of collagen [25].
Both TIMP I and TIMP II in cell culture supernatants were
detected by ELJSA as previously described (26]. The assay for
TIMP 1 was sensitive to 0.09 flM with a range up to 35 n, and
inter-assay precision of 8.2%, (CV). There was no detectable cross
reactivity with TIMP 2. The assay for TIMP 2 was sensitive to 0.15
riM, with a range up to 17.2 nsa, and inter-assay precision of 10.6%,
(CV). There was no detectable cross reactivity with TIMP 1.
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Fig. 1. Time dependent accumulation of fibronectin and type IV collagen following application of 25 mi D-glucose. Cells were grown to confluence
and serum deprived for 48 hr prior to the addition of fresh serum free media, containing 25 mvi D-glucose (U), L-glucose () or mannitol (), or 5
mM D-glucose (s). Fibronectin and type TV collagen concentration in the supernatant were determined by ELISA. Results are expressed as mean
SEM of 4 separate experiments, *J) < 0.05.
Enzymatic assays
Gelatinase activity was assayed in vitro by the degradation of
14C labeled gelatin as previously described [271. Following collec-
tion of medium, samples were centrifuged to remove any debris
present and stored at —20°C until assayed for enzymatic activity.
One hundred microliters of supernatant was incubated at 37°C
with 50 p1 of 0.4 M Tris-HCI, pH 7.5 (containing 10 mrvi CaC12)
and with 10 j.tl of 14C gelatin (1 mg/mI 0.045 rCi/mg) from
denatured interstitial rat skin collagen (95% type I, 5% type 111).
Fifty microliters of ice-cold 100% (wt!vol) trichloroacetic acid
were then added and incubated at 4°C for a further 30 minutes.
The insoluble protein was pelleted in a Beckman Microfuge at
11,000 x g for 10 minutes. One hundred and fifty microliters of
the supernatant were then dissolved in 4 ml of Ultima Gold
(Camberra Packard) and counted in an Camberra Packard Tn-
carb liquid scintillation analyzer for one minute. In Vitro activation
of gelatinasc was performed using p-Aminophcnylmercuric ace-
tate (PAMA) which was prepared to a concentration of 10 m in
0.05 M NaOH and used at I m in the enzyme assay.
Samples were also run at 4°C on a 7% non-reducing SDS
polyacrylamide gels containing gelatin at a final concentration of
1 mg/ml at 4°C. The gels were then washed in 50 mist Tris-HC1, pH
7.6, containing 10 mist CaCI2 and 0.05% Brij, and incubated in the
same buffer at 37°C overnight. The presence of gelatinasc activity
was demonstrated by zones of lysis in the Coomasie blue stained
gel [281.
RNA isolation, reverse transcription (RT), and polymerase
chain reaction (PCR) amplification
The effects of elevated D-glucose concentration on Type IV
collagen, fibronectin, gelatinase A, B and TIMP I and II gene
expression were examined by RT-PCR. At the defined time
periods total cellular RNA was extracted from both control and
stimulated cells following lysis with 4 M guanidine isothiocyanate
and centrifugation through 5.7 M cesium chloride in 0.1 M EDTA
[291. Total RNA was reverse transcribed to eDNA with M-MLV°
reverse transcriptase (Gibco Life Technologies Ltd, Paisley, UK),
using the random hexamers method as previously described [30].
Briefly, the reaction mixture contained 1 p1 random hexamers
(100 .LrvI; Pharmacia Biosystems Ltd, Milton Keynes, UK), 5 LI
NTP's (2.5 mM; Gibco/BRL Life Technologies, Ltd), 2 j.tl lox
PCR buffer (100 mist Tris/HC1, 500 mrvi KCI, 15 mist MgCl2 and
0.01% wt/vol gelatin), 2 .rl DTT (0.1 M, Gibco/BRL Life Tech-
nologies, Ltd), 1 pJ RNAase inhibitor (Promega, Southampton,
UK), I 1.d M-MLV Superscript reverse transcriptase (200 Units,
Gibco/BRL Life Technologies, Ltd) and I j.rg of total RNA.
PCR amplification was performed in a total volume of 50 pi (2
p1 of reverse transcription product and 48 pi of master mix (36.25
p1 H20, 1.25 p1 5'-primer (20 j.LM), 1.25 p1 3'-primer (20 iM), 4 1td
NTP's, 5 pA lox PCR buffer and 0.25 pJ 'Faq polymerase (2.5U,
Amplitaq, ILS Ltd, London, UK) using a Perkin Elmer 480
Thermocycler (Applied Biosystcms Ltd, Warrington, UK). The
PCR protocol for 'lGF-1 mRNA and s-actin was as follows:
The IIrst cycle was at 72°C for 10 minutes, second cycle 94°C for
3 minutes, 55°C for 1 minute, 72°C for 1 minute. The 3 through
the 38th cycles 94°C for 40 seconds, 55°C for 1 minute, 72°C for 1
minute. The final cycle was 94°C for 1 minute and 60°C for 10
minutes. PCR was performed for 32 cycles for -actin, gelatinase
A, TIMP I and 2, and 25 cycles for fibronectin and type IV (al)
collagen.
One-tenth of the PCR reaction from both test and control
(a-actin) product were mixed and separated by flat bed elcctro
phoresis in 3% wt/vol NuSieve GTG agarose gels (Flowgen
+ — + — + — +
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Instruments Ltd, Sittinghourne, UK), stained with ethidium bro-
mide (Sigma) and photographed. The negatives were scanned
using a densitometer (Model 620 video densitometer; Bio-Rad
Laboratories Ltd) and the density of the bands compared to those
of the housekeeping gene. Results were expressed as ratios of the
gene of interest to a-actin, normalized to the first time point of
each experiment. RESULTS
The sequences of the amplification primers are presented in Collagen and fibronectin production in response to 25 mM
Table 1. D-glucose
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Fig. 2. Effect of actinomycin D on the levels of mRNA for type 1V collagen and fibronectin. D-glucosc 25 m was added to confluent serum-deprived
HPTC in the presence (+) or absence (—) of 0.5 jrglml actinomycin D. Total cellular RNA was isolated, and following RT-PCR, type IV collagen A)
or fibronectin (B) and -actin mRNA were separated by flat bed clectrophoresis in 3%. Scanning densitometry confirmed that there was no difference
in the ratios of type IV collagen or fibronectin mRNA to a-actin with or without aetinomycin D. One representative experiment (N = 3), is shown.
N experiments (N = experiments performed using cells prepared
from separate nephrectomy specimens). Statistical analysis be-
tween two groups was performed using the paired Student's t-test,
with a value of P < 0.05 considered to represent a significant
difference.
1 6 12 24
Time, hours
Statistics
For each individual experiment the mean of duplicate determi-
nations was calculated. The data are presented as means SCM of
Following the addition of 25 mrvi D-glucose to growth arrested
HPTC, there was a time dependent increase in the fibronectin
concentration in cell culture supernatants. This increase was
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Gelatinase B
Latent gelatinase A
Active gelatinase A
Fig. 3. Time dependent induction of gelatinase
A by 25 mri D-glucose. Either 5 m or 25 mM
D-glucose was added to confluent serum-
deprived HPTC and supernatant samples
collected over the subsequent 24 hours.
2 2 Gelatinase activity was demonstrated following1 3 I
electrophoresis on SDS-PAGE gelatin substrate
gels under non-reducing conditions. One
Time, hours representative experiment is shown.
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Fig. 4. Time dependent induction of gelatinase A mRNA by glucose. Growth arrested TIPTC were stimulated with 25 mM D-glucose for times up to
24 hours under serum-free conditions. Following RT-PCR, gelatinase A and n-actin eDNA were separated by flat bed electrophoresis in 3% agarose
gels A) and the results expressed as the densitometric ratios of gelatinase A mRNA to a-actin normalised for the unstimulated ratio (B). One
representative experiment (N = 3) is shown.
significantly greater than that of cells exposed to 5 mM D-glucose addition of 25 mrvi D-glucose. This was also significantly elevated(P = 0.04, N = 4), 25 mt L-glucosc (P = 0.021,N = 4), or 25 m over that seen following the addition of 5 mM D-glucose (P =
mannitol (I' = 0.26, N = 4), at 48 hours (Fig. 1). Similarly there 0.03), 25 mi L-glucose (P = 0,06, N = 4), or 25 mM marinitol (Fig.
was a time dependent increase in type IV collagen following the 1).
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Fig. 5. Effect of 25 mM D-glucose on supernatant gelatinolytic activity.
D-glucose 25 m was added to growth arrested HPTC under serum-free
conditions and supernatant samples collected over the subsequent 24
hours. Gelatinase activity was assayed in vitro by the degradation of 14C
labeled gelatin. Results are expressed as % gelatinase activity of superna-
tant from 5 mM D-glucose treated HPTC for the same times, and are
expressed mean SEM, N = 3, P > 0.05.
In contrast to the increase in protein concentration for both
fibronectin and type IV collagen, there was no alteration in the
amount of corresponding mRNA as assessed by RT-PCR, for
either of these matrix constituents. Furthermore, the addition of
25 m D-glucose in the presence or absence of actinomycin D (0.5
ag/ml) did not alter the amount of mRNA for either type IV
collagen or fibronectin, again indicating that the accumulation of
protein was not dependent on new gene transcription (Fig. 2).
Metalloproteinase production in response to 25 mrsi D-glucose
Under serum free conditions 25 mivi D-glucose was added to
growth arrested HPTC, the supernatants collected over the
subsequent 24 hours, and electrophoresed on SDS-PAGE gelatin
substrate gels under non-reducing conditions. Constitutive gela-
tinolytic activity was seen at 95 kDa, corresponding to gelatinase
B. This remained unchanged following the addition of 25 mM
D-glucose. In contrast, a zone of gelatinolytic activity was induced
at 72 kDa, corresponding to gelatinase A, following addition of 25
mM D-glucose, which was not apparent in the cell culture super-
natant of growth arrested HPTC incubated with 5 mivi D-glucose
(Fig. 3).
Examination of gelatinase A mRNA by RT-PCR demonstrated
time dependent induction following the addition of 25 mM
D-glucose. Maximal induction was seen at 12 hours at which time
there was a 21% increase in the gelatinase A:a-actin mRNA ratio
(Fig. 4).
Despite the observed increase in the synthesis of gelatinase A,
there was a small but significant overall decrease in total gelatino-
lytic activity in HPTC culture supernatants following incubation in
25 mist D-glucose, as assessed by in vitro degradation of 14C
labeled gelatin (Fig. 5).
Mechanism of D-glucose dependent accumulation of collagen
and fibronectin
Effect of TGF-13 inhibition on glucose mediated alterations in
fibronectin and type IV collagen. To determine if the observed
increases in type IV collagen and fibronectin production were
mediated by the autocrine action of secreted TGF-13, 25 mist
D-glucose was added to growth arrested HPTC in the presence of
increasing concentrations of a neutralizing pan-specific TGF-f3
(1-3) antibody (Genzyme). The addition of this antibody had no
affect on the increase in fibronectin or type IV collagen seen
following the addition of 25 mist D-glucose (Fig. 9). Furthermore,
addition of the antibody did not alter the induction mRNA for
gelatinase A, TIMP 1 and TIMP 2, which was seen following the
addition of 25 mist D-glucose (data not shown).
Effect of polyol pathway inhibition on glucose mediated alterations
in fibronectin and type IV collagen. The contribution of the polyol
pathway was assessed by the addition of 25 mist D-glucose
together with increasing doses of sorhinil over 24 hours. This
compound is an inhibitor of the rate limiting enzyme of the polyol
pathway, aldose reductase. Addition of sorbinil resulted in a dose
dependent inhibition of glucose induced accumulation of type IV
collagen and fibronectin (Fig. 10). Furthermore, inhibition of
polyol pathway activation decreased glucose induced TIMP 1 and
TIMP 2 mRNA (Fig. 11) and TIMP 1 and 2 protein secretion as
assessed by ELISA (Fig. 12). Supernatant samples taken from
cells treated with 25 mM D-glucose in the presence of increasing
doses of sorbinil demonstrated increasing gelatinasc activity as
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Production of tissue inhibitors of metalloproteinase in response
to glucose
To determine the effect of elevated D-glucose concentration on
TIMP 1 and TIMP 2 production, 25 mist D-glucose was added to
* *
growth arrested HPTC under serum free conditions, and super-
natant samples collected over the subsequent 24 hours. Control
experiments were performed by incubating in the presence of 5
mM D-glucose. In the presence of 25 mM D-glucose there was a
time dependent increase in both TIMP 1 and 2 in culture
supernatants. Twenty-four hours after the addition of 25 mM
D-glucose there was an eightfold increase in TIMP I (P = 0.009,
N = 4), and a tenfold increase in TIMP 2 levels (P = 0.003, N =
4), over the control values for both inhibitors (Fig. 6). No increase
in either TIMP 1 or 2 was detected in control experiments.
Confirmation of TIMP activity in supernatant samples was
determined by the in vitro inhibition of gelatinase activity. Gela-
tinase was prepared by neutrophil gelatinase extraction as previ-0 1 3 6 12 24 ously described [271. Supernatant samples from the 24 hour time
Time hours point of the experiments in which growth arrested cells had been
exposed to 25 mist D-glucose, were serially diluted and added to
neutrophil gelatinase. Gelatinolytic activity was determined as
described above. The results demonstrated in vitro inhibition of
gelatinase activity by supernatant samples in which maximal
TIMP protein concentration was demonstrated by ELISA (Fig. 7).
Examination of TIMP 1 and 2 mRNA by RT-PCR demon-
strated time dependent induction following addition of 25 mM
D-glucose. Maximal TIMP I induction was seen at six hours, at
which time there was a 20% increase in the TIMP 1:a-actin
mRNA ratio. Similarly, TIMP 2 mRNA induction was maximal at
12 hours, when there was a 22% increase in the cs-TIMP 2:cs-actin
mRNA ratio (Fig. 8).
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Fig. 6. Time dependent induction of TIMP 1
and TIMP 2 by D-glucose. Symbols are: (U) 25
m and () 5 mat D-glucose were added to
growth arrested HPTC under serum-free
conditions. TIMP I and TIMP 2 concentrations
were determined by ELISA over the
subsequent 24 hours. Results are expressed as
mean SEM, N = 3, P > 0.05.
Glucose dependent induction of gelatinase A mRNA was inhib-
ited by both PMA pre-treatment and by the PKC inhibitor (Fig.
14). Depletion of PKC, or inhibition of PKC activity, however, did
not influence glucose induced accumulation of type IV collagen or
fibronectin, nor did they abrogate glucose induced changes in
TIMP 1 and TIMP 2 mRNA (data not shown).
DISCUSSION
Fig. 7. Gelatinase inhibitory activity of supernatant samples 24 hours
after the addition of 25 mM D-glucose to growth arrested HPTC.
Supernatant samples were serially diluted and added medium containing
neitrophil gelatinase. Gelatinase activity was assayed in vitro by the
degradation of 14C labeled gelatin. The results are presented as the %
gelatinase activity relative to gelatinase samples to which no supernatant
was added. Results are expressed as mean SCM, N = 3, *p> 0.05, **p>
0.005.
assessed by in vitro degradation of 14C gelatin (Fig. 13). Sorbinil
treatment did not affect the induction of gelatinase A mRNA
(data not shown). This suggests that the observed increase in
gelatinolytic activity following the addition of sorhinil was the
result of inhibition of TIMP production.
Etfect of PKC inhibition on glucose mediated alterations in
fibronectin and type IV collagen. The role of protein kinase C
activation was determined by PKC depletion using increasing
doses of PMA added prior to the application of 25 mat D-glucose
or by the addition of the PKC inhibitor RO-31-8220/002 together
with 25 mat D-glucose. Total cellular RNA and supernatant
samples were collected 24 hours after the addition of D-glucose.
Alterations in TBM composition occur early in the course of
diabetic nephropathy, and recent reports suggest that these
changes may precede any histological alterations within the
glomerulus, as assessed by light microscopy [71. Both in vitro and
in vivo studies have implicated elevation of glucose concentration
in the increased production of basement membrane components
by endothelial [8, 9, 37] and mesangial cells [10, 11, 38]. The data
presented in the current manuscript demonstrate that increased
amounts of both fibronectin and type IV collagen were produced
by human proximal tubular cells, when cultured in the presence of
elevated concentrations of D-glucose. Furthermore, we have
demonstrated that this effect was unrelated to alterations in
osmolarity, as neither L-glucose or mannitol reproduced the
effects seen following the addition of D-glucose. Despite the
accumulation of both basement membrane constituents in the cell
culture supernatant of 25 mat D-glucose treated cells, RT-PCR
suggested that there was no alteration in their mRNA. Experi-
ments performed in the presence of actinomycin-D confirmed
that there was no increase in gene transcription of either type IV
collagen or fibronectin following the addition of 25 mat D-glucose.
These observations are consistent with data derived from strep-
tozotocin treated rats, which have also demonstrated that in vivo,
there is no alteration in al (IV) collagen mRNA in whole kidney
[39].
Regulation of matrix synthesis is a dynamic process involving
degradation as well as synthesis. Increased synthesis and de-
creased degradation of basement membrane constituents are not
mutually exclusive, and both processes may occur simultaneously
at different rates. Altered extracellular matrix interaction with
surrounding cells may not result solely from the accumulation of
normal components, but may be the result of a distortion of the
balance between matrix synthesis and turnover [40]. The present
data demonstrate the constitutive expression of gelatinase B by
980 Phillips et a!: Glucose mediates basement membrane constituents
A
1 3 6 12 24—RT—PCR
Time, hours
Fig. 8. Time dependent induction of TIMP land TIMP 2 mRNA by D-glucose. Growth arrested HPTC were stimulated with 25mM D-glucose for times
up to 24 hours under serum free conditions. Following RT-PCR, TIMP I (A) or TIMP 2 (B) and o-actin cDNA were separated by flat bed
electrophoresis in 3% agarose gels, and the results expressed as the densitometric ratios of TIMP 1 ) or TIMP 2 () mRNAto a-actin normalized
for the unstimulated ratio (C). One representative experiment (N3) is shown.
Antibody, ng/mI
Fig. 9. Effect of anti.TGF.jJ-antibody on glucose.induced fibronectin and
type JV collagen production. Cells were grown to confluence and serum
deprived for 48 hours prior to the addition of fresh serum free-media,
containing 25 mvi D-glucose and increasing concentrations of a neutralizing
antibody to TGF-3l, -2 and -3 (Genzyme). Fibronectin () and type IV
collagen (U) concentration in the supernatant were determined by ELISA.
Results expressed as mean SM of 3 separate experiments. P < 0.05.
Fig. 10. Effect of aldose reductase inhibitor on type IV collagen and
fibronectin accumulation. HPTC were grown to confluence and serum-
deprived prior to addition of 25 mvi D-glucose in the presence of
increasing concentrations of sorbinil (0 to 100 jIM) for 24 hours. Type IV
collagen (U) and fibroneetin (fl) concentration in the supernatant were
then determined by ELISA. Results are presented as % inhibition relative
to the uninhibited control (0 M surbinil) and represent mean SFM, N =
3 * > 0.05.
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Fig. 11. Effect of aldose reductase inhibitor on TIMP 1 and TIMP 2 mRNA induction. HPTC were grown to confluence and serum-deprived prior to
addition of 25 mrvt D-glucose in the presence of increasing concentrations of sorbinil (0 to 100 fLM) for 24 hours. Following RT-PCR, TIMP I 1A) or
TIMP 2 (B) and cs-actin eDNA were separated by flat bed electrophoresis in 3% agarose gels, and the results expressed as the densitometric ratios of
TJMP I () or TIMP 2 () mRNA to o-actin normalized for the mRNA ratio in the absence of sorbinil (C). One representative experiment (N = 3)
is shown.
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Fig. 12. Effect of aldose reductase inhibitor on TIMP 1 and lIMP 2
production. HPTC were grown to confluence and serum-deprived prior to
addition of 25 mvi D-glucose in the presence of increasing concentrations
of sorhinil (0 to 100 j.sM) for 24 h. TIMP 1 (•) and TIMP 2 ()
concentration in the supernatant were then determined by ET.ISA. Results
represent mean SEM, N = 3, P > 0.05.
Sorbinil, pM
Fig. 13. Effect of aldose reductasc inhibitor on supernatant gelatinolytic
activity. 1i1'TC were grown to confluence and serum-deprived prior to
addition of 25 mM D-glueosc in the presence of increasing concentrations
of sorbinil (0 to 100 fLM) for 24 hours. Gelatinase activity was assayed in
vitro by the degradation of 4C labeled gelatin. Results are expressed as %
increase in gelatinase activity above that of superoatant samples taken
from HPTC to which 25 mri D-ghieose was added in the absence of
sorbinil, and are expressed as mean SEM, N = 3, > 0.05.
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Fig. 14. Role of PKC in the induction of gelatinase A mRNA by glucose, assessed by addition of 25 mM D-glucose to growth arrested HPTC together
with increasing doses of the PKC inhibitor RO-31-82201002 (A), or by PMA pre-treatment to deplete PKC prior to the addition of 25 msi D-glucose
(B). Following RT-PCR, gelatinase A and a-actin cDNA were separated by flat bed electrophoresis in 3% agarose gels and the results expressed as the
densitometric ratios of gelatinase A eDNA to a-aetin normalized for the eDNA ratio in the absence of either the PKC inhibitor (), or PMA
pre-treatment () (C). One representative experiment (N = 3) is shown.
HPTC, which is not affected by 25 mrvi D-glucose. In contrast,
gelatinase A mRNA and protein were both increased following
the addition of 25 mrvt D-glucose. Despite this induction, there was
a net decrease in gelatinolytic activity. This is explained by the
simultaneous induction of TIMP 1 and 2 by D-glucose. In addition
to demonstrating the increased synthesis of these two inhibitors by
ELISA, we have demonstrated their "hio-activity" in supernatants
of 25 mivi D-glucose treated HPTC. Taken together, the data
suggest that a decrease in the degradation of both type IV
collagen and fibronectin contributes to the accumulation of these
basement membrane components, under conditions of elevated
D-glucose. The data support the hypothesis that decreased deg-
radation of tubular basement membrane components may con-
tribute to TBM thickening in diabetic nephropathy, and is consis-
tent with in vivo observations on the turnover of glomcrular
basement membrane in streptozotocin-induced diabetic rats [411.
These changes in turnover of the basement membrane may
subsequently affect its functional properties and its interactions
with neighbouring proximal tubular epithelial cells.
Matrix production is controlled by a complex cytokine network.
Of all cytokines studied to date, TGF-131 has now emerged as a
key mediator of matrix remodeling in health and disease. A role
for TGF-pI cannot be inferred simply on the basis of alterations
in mRNA, as it is now clear that TGF-/31 synthesis may occur
independently at the level of transcription, translation and secre-
tion of pre-formed protein (18, 42—44]. Furthermore, it is difficult
to draw conclusions from studies in which TGF-1 protein is
measured unless latent and active TGF-f31 can be distinguished by
the assay employed. Numerous studies have implicated TGF-131 in
the extracellular matrix accumulation associated with diabetic
nephropathy [15, 16]. These in vitro studies, however, utilized
SV4O virally transformed cells, and it is known that transformation
by SV4O may be accompanied by alterations in response to
cytokines [45]. Studies utilizing non-transformed human endothe-
hal cells demonstrated inhibition of cell proliferation and in-
creased gene expression of basement components and TGF-131
upon the addition of high D-glucose concentrations [8, 37, 46].
Significantly, there was no increase in active TGF-f31 as assessed
by bioassay. Furthermore, the effects of elevated D-glucose on cell
proliferation and basement membrane component gene expres-
sions were not antagonized by the addition of neutralizing
antibodies to TGF-f3 [47]. Our previous observations have dem-
onstrated that the exposure of HPTC to elevated D-glucose
concentrations induced TGF-pl mRNA without any increase in
TGF-131 protein synthesis [18]. The data presented in the current
manuscript demonstrate that glucose mediated accumulation of
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basement membrane constituents was not mediated by autocrine
TGF-/31 production. These findings are therefore consistent with
our previous studies and also the work of other groups studying
the effects of glucose on extracellular matrix components in
non-transformed cells.
Mechanisms of glucose induced injury in other systems are
protein kinase C (PKC) activation by diacylglycerol (generated as
a result of increased glycolytic activity) [48], or the increased
activity of the polyol pathway [49—5 1]. Postulated harmful effects
of polyol pathway activation involved in the pathogenesis of
diabetes include accumulation of sorbitol, and alteration of the
redox state of the cell due to the change in NAD/NADH ratio
which accompanies the conversion of sorbitol to fructose. The
data in the current manuscript also demonstrate that the mecha-
nism of 25 mrvi D-glucose induction of TIMP I and TIMP 2
mRNA and protein synthesis were dependent upon polyol path-
way activation. Furthermore, inhibition of glucose induced TIMP
by the aldose reductase inhibitor, sorbinil, abrogated glucose-
induced accumulation of type IV collagen and fibronectiri. Under
these conditions, gelatinase A was induced by a PKC dependent
mechanism, and its unopposed action likely accounts for the
observed decrease in collagen and fibronectin.
In conclusion, we have demonstrated that exposure of cultured
non-transformed human proximal epithelial cells to 25 mtvt D-
glucose increased type IV collagen and fibronectin in the culture
supernatant. Furthermore, we have demonstrated that the accu-
mulation of these basement membrane constituents involved an
alteration in the degradative pathway, which was the result of a
net increase in TIMP 1 and TIMP 2 activity over gelatinase
activity. Finally, we have also demonstrated that glucose may
simultaneously activate two intracellular pathways, that is, the
poiyol pathway and PKC activation, which are both independently
involved in mediating its effects on cell function.
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